Related Experiment Video
Updated: Jan 11, 2026

04:09
Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
3.6K
Interpretable machine learning model for predicting recurrence in patients with diabetic foot ulcers.
Weijiao Mou1, Waiping Shan1, Shiyan Yu1
1Department of Endocrinology, School of Medicine, Chongqing University Central Hospital, Chongqing Emergency Medical Centre, Chongqing University, Chongqing, China.
BMJ Open Diabetes Research & Care
|November 13, 2025
Summary
Machine learning accurately predicts diabetic foot ulcer recurrence. The XGBoost model identified key risk factors, offering potential for improved patient management and timely interventions.
Area of Science:
- Medical Informatics
- Computational Biology
- Diabetes Mellitus Research
Background:
- Diabetic foot ulcer (DFU) presents a significant challenge due to chronic disease course and high recurrence rates.
- Accurate prediction of DFU recurrence is crucial for timely interventions and improved patient outcomes.
- This study focuses on developing a machine learning (ML) model for predicting 3-year DFU recurrence risk.
Purpose of the Study:
- To develop and validate a machine learning model for predicting the 3-year recurrence risk of diabetic foot ulcers.
- To identify key risk factors associated with DFU recurrence using ML techniques.
- To enhance clinical decision-making for patients with diabetic foot ulcers.
Main Methods:
- A cohort of 494 DFU patients was divided into training and testing sets.
- Feature selection involved LASSO, mRMR, Fisher score, and RFE; seven ML algorithms were evaluated.
- Model performance was assessed using AUROC, with calibration via Platt scaling and interpretability through SHAP analysis.
Main Results:
- The XGBoost model achieved a high predictive performance with an AUROC of 0.924.
- The calibrated XGBoost model showed good calibration with a Brier score of 0.096.
- SHAP analysis confirmed the clinical relevance of identified risk factors, aligning with existing knowledge.
Conclusions:
- The developed XGBoost model demonstrates strong predictive accuracy and clinical relevance for DFU recurrence.
- Further multicenter validation with larger sample sizes is recommended to enhance generalizability.
- The model shows promise for improving patient management and outcomes in DFU care.
Keywords:
Diabetic Foot
